Contact Us
  Search
The Business Research Company Logo
Global Pediatric Perfusion Market Report 2026
Published :January 2026
Pages :150
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Pediatric Perfusion Market Report 2026

Global Outlook – By Product (Pediatric Cannulae, Pediatric Centrifugal Blood Pumps, Pediatric Arterial Filters, Hem concentrators, Pediatric Oxygenators), By Procedure Type (Pediatric Cardiac Surgeries, Pediatric Organ Transplantation, Pediatric Extracorporeal Life Support (ECLS)), By End-User (Hospitals (Tertiary and Pediatric Specialty Hospitals), Pediatric Cardiac and Transplant Centers, Critical Care and ECMO Centers, Academic and Research Medical Centers) – Market Size, Trends, Strategies, and Forecast to 2035

Pediatric Perfusion Market Overview

• Pediatric Perfusion market size has reached to $2.83 billion in 2025 • Expected to grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Pediatric Perfusion Market Surges Amidst Rising Prevalence Of Cardiac Congenital Disorders • Market Trend: Livanova Unveils Advanced Technologies With The Essenz Heart-Lung Machine, Elevating Cardiopulmonary Bypass Surgeries • North America was the largest region in 2025.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Pediatric Perfusion Market?

Pediatric perfusion refers to a medical tool that aids in circulating blood throughout a pediatric patient's body. It is crucial for pediatric patients because it keeps their blood pressure and oxygen levels stable and ensures that blood is getting to all of their body components. The main types of pediatric perfusion products are pediatric cannulae, pediatric centrifugal blood pumps, pediatric arterial filters, hem concentrators, HMS plus hemostasis management systems, and pediatric oxygenators. Pediatric cannulae refers to a tiny tube that medical professionals place into a pediatric patient's vein or bodily cavity, such as the nose and it is used to provide intravenous (IV) therapy. They are used in procedures such as pediatric cardiac surgeries, pediatric organ transplantation, and pediatric extracorporeal life support (ECLS) by various end-users such as hospitals, clinics, ambulatory surgical centers, and others.
Pediatric Perfusion market report bar graph

What Is The Pediatric Perfusion Market Size and Share 2026?

The pediatric perfusion market size has grown strongly in recent years. It will grow from $2.83 billion in 2025 to $3.09 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising incidence of congenital heart defects, expansion of pediatric cardiac surgery programs, growing availability of specialized pediatric care centers, increasing survival rates in neonatal intensive care, improvements in extracorporeal circulation techniques.

What Is The Pediatric Perfusion Market Growth Forecast?

The pediatric perfusion market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing investments in pediatric critical care infrastructure, rising adoption of advanced monitoring technologies, increasing focus on minimally invasive pediatric surgeries, expansion of ecmo usage in pediatric respiratory failure, continued innovation in biocompatible perfusion materials. Major trends in the forecast period include increasing adoption of miniaturized pediatric perfusion devices, rising demand for ecmo systems in neonatal care, growing integration of real-time perfusion monitoring, expansion of disposable and single-use perfusion components, enhanced focus on patient-specific perfusion solutions.

Global Pediatric Perfusion Market Segmentation

1) By Product: Pediatric Cannulae, Pediatric Centrifugal Blood Pumps, Pediatric Arterial Filters, Hem concentrators, Pediatric Oxygenators 2) By Procedure Type: Pediatric Cardiac Surgeries, Pediatric Organ Transplantation, Pediatric Extracorporeal Life Support (ECLS) 3) By End-User: Hospitals (Tertiary and Pediatric Specialty Hospitals), Pediatric Cardiac and Transplant Centers, Critical Care and ECMO Centers, Academic and Research Medical Centers Subsegments: 1) By Pediatric Cannulae: Venous Cannulae, Arterial Cannulae, Dual-Lumen Cannulae 2) By Pediatric Centrifugal Blood Pumps: Continuous Flow Pumps, Pulsatile Pumps, Disposable Blood Pumps 3) By Pediatric Arterial Filters: Inline Arterial Filters, Bubble Traps, Microaggregate Filters 4) By Hemoconcentrators: Ultra-Filtration Hemoconcentrators, Continuous Renal Replacement Therapy (CRRT) Devices, Dialysis Hemoconcentrators 5) By Pediatric Oxygenators: Membrane Oxygenators, Bubble Oxygenators, Extracorporeal Membrane Oxygenation (ECMO) Systems

What Is The Driver Of The Pediatric Perfusion Market?

The prevalence of cardiac congenital disorders is expected to propel the growth of the pediatric perfusion market going forward. Cardiac congenital disorders refer to defects that are present at birth and can have an impact on the development and functionality of a baby's heart, affecting how blood travels from the heart to the body's other organs. Pediatric perfusion is extensively used during cardiac surgeries to repair or correct structural defects in the heart and these surgeries may involve procedures such as ventricular septal defect (VSD) repair, atrial septal defect (ASD) repair, tetralogy of Fallot (TOF) repair, coarctation of the aorta repair, and many others. For Instance, in February 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, congenital diseases are thought to be the cause of 240,000 newborn deaths globally within 28 days of birth each year. Furthermore, according to the report published by the Centers for Disease Control (CDC), in January 2022, a congenital cardiac abnormality affects approximately 40,000 births in the United States each year, accounting for about 1% of the global population. Therefore, the prevalence of cardiac congenital disorders is driving the growth of the pediatric perfusion industry.

Key Players In The Global Pediatric Perfusion Market

Major companies operating in the pediatric perfusion market are Medtronic plc, Terumo Cardiovascular Systems Corporation, LivaNova PLC, Eurosets, Getinge AB, Edwards Lifesciences Corporation, Smiths Medical Inc., Fresenius Kabi AG, Nipro Medical Corporation, Hemovent GmbH, Spectrum Medical Ltd., Braile Biomédica, Leviticus Cardio Ltd., B. Braun Melsungen AG, Baxter International Inc., ALung Technologies Inc., Novalung GmbH, Xenios AG, Xvivo Perfusion AB, Edwards Lifesciences Corporation

What Are Latest Mergers And Acquisitions In The Pediatric Perfusion Market?

In September 2025, OrthoPediatrics Corp., a US-based orthopedic medical device company, entered a distribution agreement with MY01 Inc. to enhance patient access and support global growth initiatives. Through this partnership, OrthoPediatrics aims to expand access to MY01’s Continuous Perfusion Sensing Technology (CPST) Platform, enabling early detection of acute compartment syndrome and improving outcomes in pediatric trauma care. MY01 Inc. is a US-based medical technology company focused on pediatric perfusion monitoring.

Need data on a specific region in this market?

Regional Outlook

North America was the largest region in the pediatric perfusion market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pediatric Perfusion Market?

The pediatric perfusion market consists of sales of heart-lung machines, oxygenators, blood pumps, cannulas, temperature management systems, and monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric Perfusion Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$3.09 billion
Revenue Forecast In 2035$4.39 billion
Growth RateCAGR of 8.9% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredProduct, Procedure Type, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies ProfiledMedtronic plc, Terumo Cardiovascular Systems Corporation, LivaNova PLC, Eurosets, Getinge AB, Edwards Lifesciences Corporation, Smiths Medical Inc., Fresenius Kabi AG, Nipro Medical Corporation, Hemovent GmbH, Spectrum Medical Ltd., Braile Biomédica, Leviticus Cardio Ltd., B. Braun Melsungen AG, Baxter International Inc., ALung Technologies Inc., Novalung GmbH, Xenios AG, Xvivo Perfusion AB, Edwards Lifesciences Corporation
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us